NoticiasCon ayuda de IA

Shilpa Pharma Lifesciences Earns Top Marks In Global Quality Audit By ANVISA-Brazil

Shilpa Pharma Lifesciences gets GMP certification from ANVISA-Brazil for Raichur facility.

Por Mrudula Kulkarni

Editor Gerente - Pharma Now

10 jul 2024Updated Jun 26, 2025 · 2 min de lectura

Compartir Añadir como fuente preferida

Shilpa Pharma Lifesciences Earns Top Marks In Global Quality Audit By ANVISA-Brazil — https://www.vbshilpa.com/research-and-development.php

Reportaje con ayuda de IA

Reviewed by Mrudula Kulkarni, Editor Gerente - Pharma Now

Shilpa Medicare Limited's subsidiary, Shilpa Pharma Lifesciences Limited, located at Raichur in Karnataka, has recently undergone a GMP inspection by ANVISA-Brazil from April 15 to April 19, 2024. Following a successful inspection, the facility has been awarded GMP Certification by ANVISA-Brazil. Specializing in manufacturing oncology and non-oncology APIs, the unit maintains a steadfast commitment to upholding GMP standards and quality norms set by Global Regulatory Authorities.

TemasNoticias

Written by

Mrudula Kulkarni

Editor Gerente - Pharma Now

My international experience as a researcher in Taiwan for three years has equipped me with a global perspective, enabling me to create content that resonates with an international audience.